Cargando…
The cardiac wound healing response to myocardial infarction
Myocardial infarction (MI) is defined as evidence of myocardial necrosis consistent with prolonged ischemia. In response to MI, the myocardium undergoes a series of wound healing events that initiate inflammation and shift to anti‐inflammation before transitioning to tissue repair that culminates in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077990/ https://www.ncbi.nlm.nih.gov/pubmed/36634913 http://dx.doi.org/10.1002/wsbm.1584 |
_version_ | 1785020417812987904 |
---|---|
author | Chalise, Upendra Becirovic‐Agic, Mediha Lindsey, Merry L. |
author_facet | Chalise, Upendra Becirovic‐Agic, Mediha Lindsey, Merry L. |
author_sort | Chalise, Upendra |
collection | PubMed |
description | Myocardial infarction (MI) is defined as evidence of myocardial necrosis consistent with prolonged ischemia. In response to MI, the myocardium undergoes a series of wound healing events that initiate inflammation and shift to anti‐inflammation before transitioning to tissue repair that culminates in scar formation to replace the region of the necrotic myocardium. The overall response to MI is determined by two major steps, the first of which is the secretion of proteases by infiltrating leukocytes to breakdown extracellular matrix (ECM) components, a necessary step to remove necrotic cardiomyocytes. The second step is the generation of new ECM that comprises the scar; and this step is governed by the cardiac fibroblasts as the major source of new ECM synthesis. The leukocyte component resides in the middle of the two‐step process, contributing to both sides as the leukocytes transition from pro‐inflammatory to anti‐inflammatory and reparative cell phenotypes. The balance between the two steps determines the final quantity and quality of scar formed, which in turn contributes to chronic outcomes following MI, including the progression to heart failure. This review will summarize our current knowledge regarding the cardiac wound healing response to MI, primarily focused on experimental models of MI in mice. This article is categorized under: Cardiovascular Diseases > Molecular and Cellular Physiology. Immune System Diseases > Molecular and Cellular Physiology. |
format | Online Article Text |
id | pubmed-10077990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100779902023-04-07 The cardiac wound healing response to myocardial infarction Chalise, Upendra Becirovic‐Agic, Mediha Lindsey, Merry L. WIREs Mech Dis Advanced Reviews Myocardial infarction (MI) is defined as evidence of myocardial necrosis consistent with prolonged ischemia. In response to MI, the myocardium undergoes a series of wound healing events that initiate inflammation and shift to anti‐inflammation before transitioning to tissue repair that culminates in scar formation to replace the region of the necrotic myocardium. The overall response to MI is determined by two major steps, the first of which is the secretion of proteases by infiltrating leukocytes to breakdown extracellular matrix (ECM) components, a necessary step to remove necrotic cardiomyocytes. The second step is the generation of new ECM that comprises the scar; and this step is governed by the cardiac fibroblasts as the major source of new ECM synthesis. The leukocyte component resides in the middle of the two‐step process, contributing to both sides as the leukocytes transition from pro‐inflammatory to anti‐inflammatory and reparative cell phenotypes. The balance between the two steps determines the final quantity and quality of scar formed, which in turn contributes to chronic outcomes following MI, including the progression to heart failure. This review will summarize our current knowledge regarding the cardiac wound healing response to MI, primarily focused on experimental models of MI in mice. This article is categorized under: Cardiovascular Diseases > Molecular and Cellular Physiology. Immune System Diseases > Molecular and Cellular Physiology. John Wiley & Sons, Inc. 2022-10-23 2023 /pmc/articles/PMC10077990/ /pubmed/36634913 http://dx.doi.org/10.1002/wsbm.1584 Text en © 2022 The Authors. WIREs Mechanisms of Disease published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Advanced Reviews Chalise, Upendra Becirovic‐Agic, Mediha Lindsey, Merry L. The cardiac wound healing response to myocardial infarction |
title | The cardiac wound healing response to myocardial infarction |
title_full | The cardiac wound healing response to myocardial infarction |
title_fullStr | The cardiac wound healing response to myocardial infarction |
title_full_unstemmed | The cardiac wound healing response to myocardial infarction |
title_short | The cardiac wound healing response to myocardial infarction |
title_sort | cardiac wound healing response to myocardial infarction |
topic | Advanced Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077990/ https://www.ncbi.nlm.nih.gov/pubmed/36634913 http://dx.doi.org/10.1002/wsbm.1584 |
work_keys_str_mv | AT chaliseupendra thecardiacwoundhealingresponsetomyocardialinfarction AT becirovicagicmediha thecardiacwoundhealingresponsetomyocardialinfarction AT lindseymerryl thecardiacwoundhealingresponsetomyocardialinfarction AT chaliseupendra cardiacwoundhealingresponsetomyocardialinfarction AT becirovicagicmediha cardiacwoundhealingresponsetomyocardialinfarction AT lindseymerryl cardiacwoundhealingresponsetomyocardialinfarction |